Recombinant Human EIF4EBP3 Protein ，His & SUMO

Eukaryotic translation initiation factor 4E-binding protein 3 (EIF4EBP3) is a member of the EIF4EBP family, which plays a critical role in the regulation of protein synthesis and cell growth. These proteins act as essential regulators of cap-dependent translation, primarily by binding to the eukaryotic translation initiation factor 4E (eIF4E), thereby inhibiting its interaction with the mRNA cap structure. The phosphorylation state of EIF4EBP3 is crucial for its function; when phosphorylated, it dissociates from eIF4E, allowing for the initiation of translation. Research has shown that EIF4EBP3 is involved in various cellular processes, including stress response, cell proliferation, and apoptosis, making it a significant player in cancer biology and metabolic diseases. Given its regulatory role, [EIF4EBP3] has emerged as a potential therapeutic target in cancer treatment, where dysregulation of translation initiation is a hallmark of tumor progression. Furthermore, understanding its precise mechanisms of action and interactions with other cellular pathways can provide insights into innovative treatment strategies. The recombinant expression of EIF4EBP3 allows for in-depth studies of its structural and functional characteristics, potentially leading to the identification of small molecules that can modulate its function. This research is essential for elucidating the broader implications of EIF4EBP3 in health and disease, opening new avenues for therapeutic development in conditions characterized by altered protein synthesis. As such, studies involving recombinant proteins like EIF4EBP3 are pivotal in both fundamental biology and translational research, highlighting their importance in the quest for targeted therapies.